• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估食管癌对诱导化疗的反应。

Assessment of response of esophageal carcinoma to induction chemotherapy.

作者信息

Hordijk M L, Kok T C, Wilson J H, Mulder A H

机构信息

Department of Internal Medicine II, University Hospital Rotterdam Dijkzigt, The Netherlands.

出版信息

Endoscopy. 1993 Nov;25(9):592-6. doi: 10.1055/s-2007-1010411.

DOI:10.1055/s-2007-1010411
PMID:8119210
Abstract

Endoscopic ultrasonography (EUS) is currently considered the best available technique for the local staging of esophageal cancer. In a prospective study 11 patients with esophageal squamous cell carcinoma were investigated to evaluate the usefulness of EUS in the assessment of response to induction chemotherapy. Response to chemotherapy was evaluated by means of history of dysphagia, endoscopy, computed tomography (CT) and EUS to assess relief of clinical symptoms, reduction of tumor bulk and depth of tumor invasion (T-stage). One patient was excluded because EUS failed. Tumor response was best correlated with relief of dysphagia and by tumor bulk reduction as determined on endoscopy and CT. We found it not useful to measure reduction of tumor bulk with EUS because of tumor compression by the instrument, stenosis, or the hypoechoic thickening of the esophageal wall caused by an inflammatory reaction after chemotherapy. There was no change in EUS T-staging after induction chemotherapy compared to prechemotherapy assessment. EUS T-staging after induction chemotherapy was accurate in 6 of 10 patients compared to the histopathologic examination of the resected specimen. There was EUS T3-overstaging in 4 patients, caused by partial or complete replacement of the tumor by an inflammatory reaction due to chemotherapy. We conclude that inflammatory changes induced by chemotherapy lead to EUS overstaging of the T stage thus making it a less reliable tool in restaging after chemotherapy.

摘要

内镜超声检查(EUS)目前被认为是食管癌局部分期的最佳可用技术。在一项前瞻性研究中,对11例食管鳞状细胞癌患者进行了调查,以评估EUS在评估诱导化疗反应中的作用。通过吞咽困难病史、内镜检查、计算机断层扫描(CT)和EUS来评估化疗反应,以评估临床症状的缓解、肿瘤体积的缩小和肿瘤浸润深度(T分期)。1例患者因EUS检查失败被排除。肿瘤反应与吞咽困难的缓解以及内镜检查和CT确定的肿瘤体积缩小最相关。我们发现,由于仪器压迫肿瘤、狭窄或化疗后炎症反应导致食管壁低回声增厚,用EUS测量肿瘤体积缩小并无帮助。与化疗前评估相比,诱导化疗后EUS的T分期没有变化。与切除标本的组织病理学检查相比,诱导化疗后EUS的T分期在10例患者中有6例是准确的。4例患者出现EUS T3期过度分期,原因是化疗引起的炎症反应部分或完全取代了肿瘤。我们得出结论,化疗引起的炎症变化导致EUS对T期过度分期,因此使其在化疗后重新分期中成为一种不太可靠的工具。

相似文献

1
Assessment of response of esophageal carcinoma to induction chemotherapy.评估食管癌对诱导化疗的反应。
Endoscopy. 1993 Nov;25(9):592-6. doi: 10.1055/s-2007-1010411.
2
Esophageal carcinoma: esophageal ultrasound assessment of preoperative chemotherapy.食管癌:术前化疗的食管超声评估
Ann Thorac Surg. 1992 Jun;53(6):972-7. doi: 10.1016/0003-4975(92)90369-f.
3
Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer.内镜超声检查用于评估食管癌患者联合放疗和化疗的疗效
Endoscopy. 1997 Jan;29(1):4-9. doi: 10.1055/s-2007-1004053.
4
Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy.内镜超声不能准确评估新辅助放化疗后食管癌的病理分期。
Am Surg. 2000 Sep;66(9):827-31.
5
Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation.新辅助放化疗后食管癌再分期中的内镜超声检查
Gastrointest Endosc. 1998 Aug;48(2):158-63. doi: 10.1016/s0016-5107(98)70157-9.
6
The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer.内镜超声在评估食管癌新辅助化疗后肿瘤反应和分期中的作用。
Surg Endosc. 2012 Feb;26(2):518-22. doi: 10.1007/s00464-011-1911-y. Epub 2011 Sep 23.
7
Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction.内镜超声检查在食管及食管胃交界腺癌患者化疗反应定量评估中的应用
Endoscopy. 1993 Nov;25(9):587-91. doi: 10.1055/s-2007-1010410.
8
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.内镜超声检查与正电子发射断层扫描-计算机断层扫描在食管鳞状细胞癌分期中的对比研究。
Dis Esophagus. 2012 Jan;25(1):40-7. doi: 10.1111/j.1442-2050.2011.01204.x. Epub 2011 May 19.
9
Accuracy of endoscopic ultrasonography for preoperative staging of esophageal malignancy.内镜超声检查对食管恶性肿瘤术前分期的准确性。
Isr J Med Sci. 1995 Feb-Mar;31(2-3):119-21.
10
Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer.食管癌新辅助化疗后的内镜超声再分期
Am J Gastroenterol. 2006 Jun;101(6):1216-21. doi: 10.1111/j.1572-0241.2006.00692.x.

引用本文的文献

1
Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning.计算机断层扫描高估食管肿瘤长度:对放射治疗计划的影响。
World J Gastrointest Oncol. 2010 Apr 15;2(4):197-204. doi: 10.4251/wjgo.v2.i4.197.
2
Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapy.使用定量逆转录聚合酶链反应(Q-RT-PCR)检测细胞周期蛋白D1、胸苷合成酶(TS)、拓扑异构酶(TP)、二氢嘧啶脱氢酶(DPD)和人表皮生长因子受体2(Her-2/neu),以预测食管鳞状细胞癌患者放化疗后的反应、生存和复发情况。
Int J Colorectal Dis. 2009 Jan;24(1):69-77. doi: 10.1007/s00384-008-0562-5. Epub 2008 Aug 13.
3
The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging.
使用动态对比增强磁共振成像对食管腺癌进行评估。
J Gastrointest Surg. 2008 Jan;12(1):166-75. doi: 10.1007/s11605-007-0253-5. Epub 2007 Sep 1.
4
[MSCT for staging and response evaluation of esophageal cancer].[多层螺旋CT用于食管癌的分期及疗效评估]
Radiologe. 2007 Feb;47(2):101-9. doi: 10.1007/s00117-006-1455-7.
5
Serial endoscopic ultrasound in the assessment of response to chemoradiotherapy for carcinoma of the esophagus.连续内镜超声在评估食管癌放化疗反应中的应用
J Gastrointest Surg. 1999 Sep-Oct;3(5):462-7. doi: 10.1016/s1091-255x(99)80098-5.